Immucell Corp.
ICCC - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$93.18M
Close$
$6.58
37.7% downside
Current Fair Value
37.7% downsideOvervalued by 37.7% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $93.18 Million |
|---|---|
| Enterprise Value | $89.97 Million |
| Earnings per Share | $-0.12 |
| Beta | 0.57 |
| Outstanding Shares | 9,064,785 |
Return
| Return on Equity | 2.51% |
|---|---|
| Return on Assets | 1.69% |
| Return on Invested Capital | 9.29% |
Valuation & Multiples
| P/E Ratio | 121.28 |
|---|---|
| PEG | 45.67 |
| Price to Sales | 3.52 |
| Price to Book Ratio | 3.52 |
| Enterprise Value to Revenue | 2.93 |
| Enterprise Value to EBIT | 22.95 |
| Enterprise Value to Net Income | 114 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.18 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 19, 2026
EPS Estimate
$-0.08
Consensus analyst estimateRevenue Estimate
$3.26 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$0.05
Consensus analyst estimateRevenue Estimate
$5.40 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.30%▼ 14.71% |
|---|---|
| Total Invested | $264,355▼ 98.07% |
| Investors Holding | 3▼ 29.00% |
About Immucell Corp.
CEO: Michael Brigham
